These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 28852382)

  • 1. Mitochondrial quality control in amyotrophic lateral sclerosis: towards a common pathway?
    Khalil B; Liévens JC
    Neural Regen Res; 2017 Jul; 12(7):1052-1061. PubMed ID: 28852382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteinopathies as Hallmarks of Impaired Gene Expression, Proteostasis and Mitochondrial Function in Amyotrophic Lateral Sclerosis.
    Benson BC; Shaw PJ; Azzouz M; Highley JR; Hautbergue GM
    Front Neurosci; 2021; 15():783624. PubMed ID: 35002606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy that is disrupted by an ALS-linked mutation.
    Wong YC; Holzbaur EL
    Proc Natl Acad Sci U S A; 2014 Oct; 111(42):E4439-48. PubMed ID: 25294927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring new pathways of neurodegeneration in ALS: the role of mitochondria quality control.
    Palomo GM; Manfredi G
    Brain Res; 2015 May; 1607():36-46. PubMed ID: 25301687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALS-Related Mutant SOD1 Aggregates Interfere with Mitophagy by Sequestering the Autophagy Receptor Optineurin.
    Tak YJ; Park JH; Rhim H; Kang S
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33065963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic recruitment and activation of ALS-associated TBK1 with its target optineurin are required for efficient mitophagy.
    Moore AS; Holzbaur EL
    Proc Natl Acad Sci U S A; 2016 Jun; 113(24):E3349-58. PubMed ID: 27247382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy as a common pathway in amyotrophic lateral sclerosis.
    Nguyen DKH; Thombre R; Wang J
    Neurosci Lett; 2019 Apr; 697():34-48. PubMed ID: 29626651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligogenic inheritance of optineurin (OPTN) and C9ORF72 mutations in ALS highlights localisation of OPTN in the TDP-43-negative inclusions of C9ORF72-ALS.
    Bury JJ; Highley JR; Cooper-Knock J; Goodall EF; Higginbottom A; McDermott CJ; Ince PG; Shaw PJ; Kirby J
    Neuropathology; 2016 Apr; 36(2):125-34. PubMed ID: 26303227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyotrophic Lateral Sclerosis (ALS): Stressed by Dysfunctional Mitochondria-Endoplasmic Reticulum Contacts (MERCs).
    Chen J; Bassot A; Giuliani F; Simmen T
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA Damage, Defective DNA Repair, and Neurodegeneration in Amyotrophic Lateral Sclerosis.
    Konopka A; Atkin JD
    Front Aging Neurosci; 2022; 14():786420. PubMed ID: 35572138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyotrophic lateral sclerosis-associated mutant SOD1 inhibits anterograde axonal transport of mitochondria by reducing Miro1 levels.
    Moller A; Bauer CS; Cohen RN; Webster CP; De Vos KJ
    Hum Mol Genet; 2017 Dec; 26(23):4668-4679. PubMed ID: 28973175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing mitochondrial calcium buffering capacity reduces aggregation of misfolded SOD1 and motor neuron cell death without extending survival in mouse models of inherited amyotrophic lateral sclerosis.
    Parone PA; Da Cruz S; Han JS; McAlonis-Downes M; Vetto AP; Lee SK; Tseng E; Cleveland DW
    J Neurosci; 2013 Mar; 33(11):4657-71. PubMed ID: 23486940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkin is a disease modifier in the mutant SOD1 mouse model of ALS.
    Palomo GM; Granatiero V; Kawamata H; Konrad C; Kim M; Arreguin AJ; Zhao D; Milner TA; Manfredi G
    EMBO Mol Med; 2018 Oct; 10(10):. PubMed ID: 30126943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organelle-specific autophagy in inflammatory diseases: a potential therapeutic target underlying the quality control of multiple organelles.
    Yao RQ; Ren C; Xia ZF; Yao YM
    Autophagy; 2021 Feb; 17(2):385-401. PubMed ID: 32048886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome Proliferator Activator Receptor Gamma Coactivator-1α Overexpression in Amyotrophic Lateral Sclerosis: A Tale of Two Transgenics.
    Varghese M; Zhao W; Trageser KJ; Pasinetti GM
    Biomolecules; 2020 May; 10(5):. PubMed ID: 32414179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal dynamics of PARK2/parkin and OPTN/optineurin recruitment during the mitophagy of damaged mitochondria.
    Wong YC; Holzbaur EL
    Autophagy; 2015; 11(2):422-4. PubMed ID: 25801386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-deposition of SOD1, TDP-43 and p62 proteinopathies in ALS: evidence for multifaceted pathways underlying neurodegeneration.
    Trist BG; Fifita JA; Hogan A; Grima N; Smith B; Troakes C; Vance C; Shaw C; Al-Sarraj S; Blair IP; Double KL
    Acta Neuropathol Commun; 2022 Aug; 10(1):122. PubMed ID: 36008843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal dysfunction caused by FUSR521G promotes ALS-associated phenotypes that are attenuated by NF-κB inhibition.
    Pelaez MC; Desmeules A; Gelon PA; Glasson B; Marcadet L; Rodgers A; Phaneuf D; Pozzi S; Dutchak PA; Julien JP; Sephton CF
    Acta Neuropathol Commun; 2023 Nov; 11(1):182. PubMed ID: 37974279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fundamental roles of the Optineurin gene in the molecular pathology of Amyotrophic Lateral Sclerosis.
    Zhao S; Chen R; Gao Y; Lu Y; Bai X; Zhang J
    Front Neurosci; 2023; 17():1319706. PubMed ID: 38178841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial Dyshomeostasis as an Early Hallmark and a Therapeutic Target in Amyotrophic Lateral Sclerosis.
    Belosludtseva NV; Matveeva LA; Belosludtsev KN
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.